The number and volume of cells in the blood affect a wide range of disorders including cancer and cardiovascular, metabolic, infectious and immune conditions. We consider here the genetic variation in eight clinically relevant hematological parameters, including hemoglobin levels, red and white blood cell counts and platelet counts and volume. We describe common variants within 22 genetic loci reproducibly associated with these hematological parameters in 13,943 samples from six European population-based studies, including 6 associated with red blood cell parameters, 15 associated with platelet parameters and 1 associated with total white blood cell count. We further identified a long-range haplotype at 12q24 associated with coronary artery disease and myocardial infarction in 9,479 cases and 10,527 controls. We show that this haplotype demonstrates extensive disease pleiotropy, as it contains known risk loci for type 1 diabetes, hypertension and celiac disease and has been spread by a selective sweep specific to European and geographically nearby populations.
A r t i c l e s
The hematopoietic system is one of the best-studied cellular differentiation processes in mammals. The differentiation of the hematopoietic stem cell into its progeny is a tightly orchestrated process of fate determination and cell proliferation which results in a repertoire of different types of mature cells in the peripheral blood that supervise a range of functions including the transport of oxygen, innate and adaptive immunity, vessel wall surveillance, homeostasis and wound repair. The count and volume of the cellular elements in circulating blood are highly heritable and tightly regulated 1, 2 and vary widely between individuals. Such hematological traits, which include the concentration of hemoglobin (Hb), the numbers of white blood cells (WBC), red blood cells (RBC) and platelets (PLT), and the volumes of red blood cells and platelets (MCV and MPV, respectively), are commonly used parameters in the clinic. Deviations outside normal ranges for these parameters are indicative of many different disorders including cancer and infectious and immune diseases. Multiple reports confirm that high white cell counts are an independent risk factor for coronary artery disease (CAD) and myocardial infarction (MI) [3] [4] [5] . Increased platelet volume has also been variably associated with MI risk 6 .
We established the HaemGen Consortium in order to search for genetic loci contributing to variation in hematological parameters and to assess the potential correlation of these loci with disease A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium
loci associated with hematological parameters
Of the 89 SNPs with replication data, 23 SNPs from 22 regions (including both SNPs in the 12q24 region) had nominally significant P values in the replication sample and reached genome-wide significance at the 
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threshold of 5 × 10 -8 in the combined sample of 13,943 individuals ( Table 1 ; the summary statistics for loci that did not reach this threshold are given in Supplementary Table 2). Of the 22 loci, 7 are known loci for hematological parameters, and the remaining 15 identify new association signals. We searched published literature, databases of mendelian human disease (Online Mendelian Inheritance in Man), gene function and homology with animal models of function and disease in order to prioritize the most likely candidate genes (Supplementary Table 3 ). Furthermore, we characterized the expression patterns of all the genes within a 1-Mb interval from the lead SNP in eight blood cell lines and endothelial cells using Illumina HumanWG-6 (v2) Expression BeadChip expression arrays ( Supplementary Fig. 1 and Supplementary Note). Finally, for platelet loci, we also tested associations with transcript level in a panel of 35 platelet mRNAs. Although this effort provides supplementary evidence to prioritize a list of the most plausible candidates in each region, we note that more in-depth characterization will be required in order to conclusively associate genes with the observed phenotypic variation.
Red blood cell traits. Six independent regions were confirmed as strongly associated with red blood cell parameters with all exerting their main effect on MCV or RBC ( Table 1) . Among these regions were two well-characterized loci: the HBS1L-MYB region on 6q23-q24 (rs9402686, P = 7.4 × 10 -42 ) and the C282Y amino acid change in HFE at 6p21.3 (rs1800562, P = 1.4 × 10 -23 ). Rare nonsynonymous mutations in these genes have been associated with hereditary hemochromatosis and common SNPs with measures of iron status (Supplementary Table 3) . Of the red cell loci, the HBS1L-MYB locus had the greatest pleiotropic effect, showing genome-wide significant associations with MCH (P = 4.5 × 10 -40 ), RBC (P = 1.6 × 10 -29 ), PLT (P = 2.2 × 10 -13 ) and, to a lesser extent, MCHC (P = 1.2 × 10 -5 ) and WBC (P = 6.3 × 10 -5 ; Supplementary Table 4) . Two other association signals were located near genes known to play a role in iron hemostasis (TMPRSS6 and TFR2). The serine protease matriptase-2, encoded by TMPRSS6 (lead SNP rs5756506, P = 9.5 × 10 -10 ), regulates levels of the peptide hormone hepcidin, the master regulator of iron homeostasis in humans 9 . The rs5756506 SNP was the only For each locus, the association statistics were calculated using inverse-variance meta-analysis separately in the three discovery (UKBS-CC1, TwinsUK and KORA F3 500K) and three replication samples (KORA F4, SHIP and CBR) and in the combined sample. I 2 (%) measures the percentage of total variation across studies due to heterogeneity. Most of the loci show small to moderate heterogeneity, with only rs647316 displaying substantial heterogeneity (I 2 = 59%).
a A1/A2 aligned to CEU + strand, increaser allele. b After replication, this locus was most significant for MCV (Beta = 0.369 (0.056), P = 3.8 × 10 −11 ).
red-blood-cell locus to be strongly associated with Hb levels (P = 3.4 × 10 -8 , Supplementary Table 4); the only other red blood cell locus with a nominal effect on Hb was HFE (P = 1.6 × 10 -4 ). The signal on chromosome 7q22 (rs7385804, P = 4.9 × 10 -10 ) is centered on the TFR2 gene, which encodes the type-2 transferrin receptor essential to cellular uptake of transferrin-bound iron 10 . Another likely candidate in this gene-dense region is EPO (erythropoietin), a growth factor critical for fate determination within the erythroid lineage 11 . Another newly identified MCV locus on chromosome 6p21.1 (rs11970772, P = 7.0 × 10 -19 ) maps to a recombination interval near the BYSL and CCND3 genes. We found that five out of the seven genes in the BYSL-CCND3 region were abundantly transcribed in hematopoietic cells (Supplementary Fig. 1 ). Both BYSL and CCND3 have roles in hematopoiesis (Supplementary Table 3 ). BYSL (bystin) is a target of c-MYC mRNA, which is consistent with a role in rapid protein synthesis required for actively growing cells 12 . Ccnd3 -/-mice show lethality due to heart abnormalities combined with severe anemia 13 . Finally, the association signal for MCV at 22q12-q13 overlaps with FBXO7 (rs9609565, P = 4.3 × 10 -10 ), a gene highly expressed in erythroblasts (EBs), which are the precursors of red blood cells (Supplementary Fig. 1 ).
White blood cell counts. One association signal for the total number of leukocytes was identified on 17q12 near GSDMA-ORMDL3
(rs17609240, P = 9.4 × 10 -9 ), a known susceptibility locus for childhood asthma 14 . Notably, this locus contains CSF3, which encodes colony stimulating factor 3, a cytokine controlling the production, differentiation and function of granulocytes 15 .
Platelet counts and mean platelet volume. In addition to the four loci associated with MPV (WDR66, ARHGEF3, TAOK1 and PIK3CG) previously described by our groups 7, 8 , we detected eight new loci associated with MPV and the first three loci found to be associated with PLT ( Table 1 , Supplementary Fig. 1 ). Nine of the 12 MPV loci were also associated w ith PLT, of which three reached genome-wide significance in the combined sample. In all cases the MPV-raising alleles were associated with a decrease in PLT (Supplementary Table 4 ). Conditional analyses show however that all SNPs exerted their main effects through MPV (Online Methods).
Of the newly identified MPV-associated loci, the association signals on chromosome 1q24.3 (DNM3, rs10914144, P = 2.1 × 10 -14 ) and 18q22.3 (CD226, rs893001, P = 1.4 × 10 -10 ) contained two strong and highly plausible candidate genes with a known role in megakaryocyte (MK) development (Supplementary Table 3 ) and enhanced gene expression in MKs when compared with EBs ( Supplementary  Fig. 1 ). Four additional regions map in or near JMJD1C (rs2393967, P = 3.3 × 10 -21 ), TPM1 (rs11071720, P = 1.9 × 10 -8 ), SIRPA (rs6136489, P = 7.7 × 10 -11 ) and EHD3 (rs647316, P = 3.2 × 10 -11 ), which are candidates with indirect evidence for a role in hematopoiesis in humans (as discussed in Supplementary Table 3) . Of these genes, JMJD1C (10q21) encodes a probable histone demethylase, with a possible function in hormone-dependent transcriptional activation. Mouse mutated at Jmjd1c (encoding Jumonji domain containing 1C) display increased proliferation of MK lineage cells 16 . TPM1 encodes tropomyosin I, which regulates the calcium-dependent interaction of actin and myosin, a key step in platelet formation. TPM1 was found to be highly downregulated in an individual with an unique mutation in RUNX1 (also called CBFA2) and a severe platelet function disorder 17 . Finally, two newly identified regions at 1q32.1 and 11p15.5 are gene rich, and further efforts will be required to identify the most likely gene candidates for association with MPV. The 11p15.5 signal maps to a region proximal to the genes BET1L, SIRT3 and PSMD13 (among others). In this region, we found evidence that the lead SNP rs11602954 affects expression of the two neighboring genes BET1L (Spearman's test P = 3.1 × 10 -5 ) and SIRT3 (P = 2.8 × 10 -5 ) as well as PSMD13 to a lesser degree (P = 7.3 × 10 -3 , see Supplementary Note and Supplementary  Fig. 1 ). A G477T variant in the SIRT3/PSMD13 bidirectional promoter has been shown to co-regulate SIRT3 and PSMD13 and has been 
linked to longevity in humans 18 . Three independent loci with effects on PLT were identified. The association signal on the 6p21.3 locus was centered in the BAK1 gene (rs210135, P = 3.7 × 10 -10 ), which encodes a protein with a strong proapoptotic effect that is known to control platelet lifespan 19 . Two further SNPs map to 12q24.12 (rs11065987, P = 2.2 × 10 -13 and rs11066301, P = 7.7 × 10 -12 ). The association signal on 12q24.12 spans ~1.6 Mb and harbors 15 genes including PTPN11, SH2B3 and BRAP. This region is discussed in more detail below. Finally, an association signal at 9p24.1-p24.3 (rs385893, P = 8.5 × 10 −17 ) was found 400 kb upstream of JAK2, which is a key regulator of megakaryocyte maturation and is somatically mutated in half of the individuals with essential thrombocytosis 20 .
Multimarker scores
Overall, the fraction of genetic variance explained by each locus in regression models adjusted for sex and age was 8.6% for MPV traits, 0.5% for PLT traits, 3% for erythrocyte traits and 0.12% for the single validated WBC locus. We constructed a score to predict MPV levels from the joint model of the 12 validated MPV SNPs and the 6 validated SNPs associated with red blood cell traits as described in the Online Methods section (Fig. 3) . The regression of mean on score indicates an average increase of MPV of 0.12 fl per copy of a MPVincreasing allele and 0.47 fl per copy of a MCV-increasing allele.
Associations with coronary artery disease
Because several of the hematological traits analyzed show an association with CAD or MI, we examined the association of the 23 validated SNPs (including the two associated SNPs on 12q24.12) with CAD. We used a two-stage approach to test for association with CAD ( Fig. 1) The association results for the two SNPs rs11066301 and rs11065987 on 12q24 were strongly replicated in the stage 2 sample, providing independent confirmation for 12q24 as a risk locus for CAD. In the combined sample of 9,479 cases and 10,527 controls, the allelic odds ratios of rs11066301 (minor allele frequency (MAF) = 0.35) and rs11065987 (MAF = 0.34) were, respectively, 1.144 (95% CI 1.095-1.196, P = 2.52 × 10 -9 ) and 1.152 (95% CI 1.104-1.202, P = 7.05 × 10 -11 Fig. 4 and Supplementary Table 5a) ; the respective allelic odds ratios for a MI sub-analysis were 1.165 (95% CI 1.111-1.222, P = 3.43 × 10 -10 ) and 1.177 (95%CI 1.124-1.231, P = 2.42 × 10 -12 ; Supplementary Table 5b). For both SNPs, the minor allele was associated with increased PLT and increased risk of CAD and MI. The same association with CAD was recently reported by an independent study 21 .
Natural selection and human disease at the 12q24 locus
The SNPs rs11065987 and rs11066301 are located 799 kb apart and are in high LD (r 2 = 0.82). Analysis of the PLT association plot shows that the signals map to two adjacent recombination intervals spanning approximately 1.6 Mb and containing 15 genes. The expression of such genes in blood lineages is shown in Figure 5 . The haplotype structure of this region is shown in Figure 6 . We analyzed the local LD pattern in three HapMap population panels (CEU, CHB + JPT, and YRI). In the CEU panel, the region is characterized by extended LD. Ten common SNPs (MAF = 0.35-0.4) identify a common haplotype spanning the length of the associated interval ( Table 2) . Of the ten SNPs, one is an Arg262Trp nonsynonymous change in the gene SH2B3 (rs3184504), seven are intronic within four genes (ATXN2, C12orf30, C12orf51 and PTPN11) and two are intergenic. All of them display genome-wide significant association with PLT (Fig. 6a) . We calculated the pooled summary statistics for associations with CAD in the same 1.6 Mb region using six of the eight case-control studies with available data. The ten SNPs had similarly elevated P values for association with CAD ( Table 2, see also Supplementary Table 5) , whereas the remaining SNPs FAM109A  SH2B3  ATXN2  BRAP  ACAD10  ALDH2  MAPKAPK5  TMEM116  ERP29  C12orf30  TRAFD1  C12orf51  RPL6  PTPN11   CUX2  FAM109A  SH2B3  ATXN2  BRAP  ACAD10  ALDH2  MAPKAPK5  TMEM116  ERP29  C12orf30  TRAFD1  C12orf51  RPL6 PTPN11 RPH3A Figure 5 Heat map of mRNA expression in the 12q24 region. For all genes contained within the 1.6-Mb interval, VST-transformed signal intensities from using Illumina HumanWG-6 (v2) Expression BeadChip expression arrays were median-normalized and values were averaged across biological replicates in stem cell-derived erythroblasts (EBs, n = 4), megakaryocytes (MK, n = 4), human umbilical vein endothelial cells (HUVECs, n = 3), CD4 + Th (CD4, n = 7) and CD8 + Tc lymphocytes (CD8, n = 7), CD14 + monocytes (CD14, n = 7), CD19 + B lymphocytes (CD19, n = 7), CD56 + natural killer cells (CD56, n = 7) and CD66b + granulocytes (CD66, n = 7). For platelet-associated signals, levels of gene expression in 35 platelet mRNA were averaged based on genotype at the leading or proxy SNP. Signal intensities obtained with platelets were obtained using Illumina HumanWG-6 (v1) Expression BeadChip expression arrays and were normalized independently from the remaining blood cell lines.
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in the region did not show strong association with CAD (Fig. 6b) . The G allele at rs17696736 in C12orf30 is a known risk factor for type 1 diabetes (T1D) 22, 23 . A second SNP on the same haplotype (rs3184504 in SH2B3) has been previously associated with celiac disease, whereby the CAD risk allele also increases risk for celiac disease 24 . We retrieved association data for T1D and celiac disease generated in previous studies (Supplementary Note) and plotted the association statistics for genotyped and imputed SNPs over the same interval (Fig. 6c,d ). We observed a similar elevation of the association signals at the ten SNPs (where present), which suggests a pattern of association similar to PLT and CAD. We retrieved the ancestral states by comparison with chimpanzee data from the University of California at Santa Cruz genome browser for each of the ten SNPs showing significant association with PLT ( Table 2 ). The CAD-risk and PLT-raising alleles corresponded to the derived states. We retrieved the integrated haplotype score (iHS) 25, 26 and Fay and Wu's H + statistics for HapMap Phase II data ( Table 2) [25] [26] [27] to test the hypothesis that the long-range, evolutionarily derived haplotype in this region arose from a positive selection event-that is, a selective sweep. The 12q24 region showed a signature characteristic of a selective sweep, with highly negative iHS scores (-4.341 to -2.756, an extreme pattern compared to an empirical genome-wide threshold of -2 for positive selection 25 ) and highly skewed Fay and Wu's H+ statistics ( Table 2) . Accordingly, the extended haplotype homozygosity statistics 28 show excess homozygosity on the evolutionarily derived haplotype over a 1.6-Mb interval (Fig. 6g) . We estimated the age of the rs3184504 T-allele haplotype 25 at approximately 3,400 years (Supplementary Note). Next, we compared the population differentiation statistics F ST at the ten SNPs with the empirical distributions of frequencymatched HapMap SNPs ( Table 2) 29 . The ancestral alleles at all SNPs were fixed in the YRI and CHB+JPT HapMap panels, yielding significant global differentiation ( Table 2) . Taken together, these results support the hypothesis of a selective sweep that increased the frequency of CAD, T1D and celiac disease risk alleles in Europeans and geographically nearby populations but not in East Asian or African populations.
DISCUSSION
This study represents, to our knowledge, the first GWA of hematological parameters to be completed in cohorts with large sample sizes. In a two-stage design with 4,627 discovery and 9,316 replication samples, we were able to confirm 22 independent loci as associated with six of the eight traits at the genome-wide significance level. None of the loci selected from the meta-analysis of MCHC and Hb were replicated at genome-wide significance in our study. However, genome-wide significance for Hb was achieved for rs5756506 at locus TMPRSS6 in the combined analysis (Supplementary Table 4) . The regions identified contain several plausible regulators of hematopoiesis in humans (see also Supplementary Table 3 for discussion on likely candidates). Associations with erythrocyte-related traits are dominated by two main effect loci, rs1800562 in HBS1L-MYB and the nonsynonymous 
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change rs9402686 in HFE. Three loci (HFE, TFR2 and TMPRSS6) mapped to genes known to be associated with iron homeostasis. The nonsynonymous C282Y change in HFE (rs9402686) is a classic risk allele for hereditary hemochromatosis, but here we show for the first time that it also modifies MCV. The 12 MPV loci showed similar per-allele effect sizes ( Table 1 ) and jointly explain 8.6% of total genetic variance in MPV after adjusting for age and sex. We identified several key functional categories of genes implicated in the regulation of platelet counts and volume, including transcriptional activation (WDR66 and JMJD1C), intracellular signaling (PIK3CG, ARHGEF3, TAOK1 and SH2B3), protein transport and endocytosis (BET1L, DNM3 and EHD3), cell adhesion (SIRPA and CD226) and actin-myosin contraction and cell motility (TPM1) and apoptosis (BAK1). Of these, only a handful of loci encode proteins that had previously known roles in hematopoiesis in humans and mouse knockout models (PIK3CG-PRKAR2B, ARHGEF3, JMJD1C, CD226, BAK1, SH2B3-PTPN11 and SIRPA). SIRPA and CD226 both encode MK membrane proteins; results from cell biology studies in MK cells are strongly supportive of their candidacy for association to MPV (Supplementary Table 3) . The marked overexpression of DNM3 in MKs compared with other blood cells and the increase in the TPM1 transcript level with MK polyploidization both support of the putative role of these proteins in MK and platelet biology, but further studies will be required to discern their precise role.
We also detected a greater number of loci for MPV than for red and, particularly, white blood cell traits. Measurements of WBC included all different white cell subtypes, thus adding to the overall noise in the association analysis and lowering power. It is possible that dissecting the WBC measurement into the main types of mononuclear cellular elements (lymphocytes, monocytes and granulocytes) may improve the ability to identify a large number of additional loci. A recent study identified an association of the Arg262Trp nonsynonymous change in the gene SH2B3 (rs3184504) and eosinophil counts and CAD (P = 8.6 × 10 -8 ) 21 . The same locus was identified in our study as being strongly associated with PLT and CAD.
We extended knowledge of this locus by characterizing the association signal as a common (frequency ~40%) long-range haplotype (1.6 Mb) including the Arg262Trp site, seven intronic SNPs (in ATXN2, C12orf30, C12orf51 and PTPN11) and two intergenic SNPs. We obtained strong evidence suggesting that the haplotype at 12q24 has arisen from a selective sweep specific to Europeans and nearby populations beginning approximately 3,400 years ago, a period characterized by the expansion of high-density human settlements in this part of the world. The role of this region in T cell-mediated immune response is compatible with the notion of immunity being a strong selective force in human evolution 28 .
The 12q24 haplotype links risk alleles for T1D, CAD and celiac disease (carried on the derived haplotype) as well as a recently identified association with hypertension 30 , thus highlighting a remarkable example of disease pleiotropy at this locus. The functional validation of the effect of the Arg262Trp variant in SH2B3 and other variants on this haplotype will be important to clarify and dissect the underlying causes of such pleiotropy and also to establish whether variation in PLT and/or the Arg262Trp change are causal for CAD or whether they merely reflect a pleiotropic effect due to the persistence of multiple functional variants on the long-range haplotype. SH2B3 encodes Lnk, an important negative regulator of cell-signaling events originating from cell membrane activatory receptors such as the T-cell receptor and MPL, the receptor for thrombopoietin on MKs and platelets. Lnk-mediated regulation of Stat-5 activation regulates the crosstalk between integrin-and cytokinemediated signaling 31 . Cells from Lnk-deficient mice show an increased sensitivity to several cytokines and altered activation of the RAS-MAPK pathway in response to IL3 and stem cell factor 32 . Using homology to mouse protein models, we mapped Arg262Trp to a putative pleckstrin homology domain (Supplementary Note and Supplementary Fig. 2) . A possible functional effect could be caused by a charge reversal of this surface-exposed residue, affecting interaction with unidentified downstream signaling molecules. Pleckstrin homology domains form a structurally conserved family associated with several regulatory pathways through signal transduction or protein ligand recognition 33 .
Further functional assessment and in-depth analysis of the 12q24 region will be required to dissect the pleiotropic effects observed at this locus and, in particular, the causality relationship between platelet counts and CAD risk. We note that the region covered by the 
long-range haplotype contains a number of other candidate genes that may modify platelet phenotypes. The tyrosine-protein phosphatase non-receptor type 11 encoded by PTPN11 plays a regulatory role in a wide array of cell-signaling events involved in the control of cell functions, such as mitogenic activation, metabolic control, transcription regulation and cell migration. Mutations in PTPN11 are a cause of the mendelian disorder Noonan syndrome, which is characterized by platelet abnormalities 34, 35 and acute myeloid leukemias 36, 37 . Also in this region, BRAP (encoding BRCA1-associated protein) was shown to interact in vitro and in vivo with p21 (encoded by CDKN1A), a regulator of cell cycle progression previously implicated in atherosclerosis 38 . Notably, a recent study in Japanese individuals has detected an association between common SNPs in BRAP and risk of CAD 39 . Such an effect, however, is not explained by the Arg262Trp variant in SH2B3, which is absent in East Asian populations. An overarching scope of our analysis was to test whether blood cell loci, particularly those for platelets, are risk loci for cardiovascular disease. Apart from the association signal on 12q24, we found no overwhelming evidence for contribution of these loci to the risk of CAD or MI. Increased MPV represents a strong, independent predictor of post-event outcome in CAD 6, [40] [41] [42] , and the new loci might contribute to survival and prognosis after a major CAD event. This possibility merits further investigation. Finally, the regions identified provide new targets to study in a range of other related diseases. For example, platelets are proposed as having a role in cancer progression and metastasis, which has largely been attributed to platelet-mediated enhancement of tumor cell survival, extravasation and angiogenesis. It has been proposed that platelet inhibition may slow the rate of tumor progression and metastasis. Further characterization of these loci will improve our understanding of key regulatory mechanisms of hematopoiesis in humans and may also lead to the discovery of new candidate genes that are somatically mutated in premalignant conditions such as essential thrombocytosis and polycythemia vera and in other hematological malignancies.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
ONLINE METhODS

Study design and population description for analysis of intermediate traits.
The study design is summarized in Figure 1 . For analysis of intermediate hematological traits, we used a two-stage design.
Stage 1 (Discovery). A discovery set of 4,627 healthy individuals was sampled from the general population from three population-based cohorts: (i) 1,221 healthy donors from the UK Blood Services Common Control (UKBS-CC1) collection of the Wellcome Trust Case Control Consortium (WTCCC) 22 ; (ii) 1,050-1,763 (depending on trait) individuals from the TwinsUK adult twin registry; (iii) 1,606-1,643 (depending on trait) individuals from the from the Kooperative Gesundheitsforschung in der Region Augsburg (KORA) F3 500K study population 43, 44 .
Stage 2 (Replication). The replication set included 9,316 individuals from three additional European population-based studies: (i) Study of Health in Pomerania (SHIP) from West Pomerania (n = 4,092); (ii) KORA F4 (n = 1,814); (iii) Cambridge BioResource (CBR, n = 3,410).
All participants are of European ancestry. Approval was obtained from local ethics committees for all studies, and informed consent was obtained from the study participants. The detailed characteristics of the sample collections are described in Supplementary Table 1a and in the Supplementary Note. Genotyping and imputation. Three different platforms were used for genotyping: the Affymetrix 500K GeneChip array (UKBS-CC1 and KORA F3), the Affymetrix 6.0 GeneChip array (KORA F4 and SHIP) and Illumina HumanHap300 (TwinsUK). All datasets were imputed using genotype data from the HapMap project 45 . As is standard for imputation, we excluded all X-linked SNPs for the following reasons: (i) the X chromosome has to be treated differently from the autosomes; (ii) it cannot be predicted which allele is active on the X chromosome, (iii) testing males separately from females results in different sample sizes and power. Imputation of SNPs in the HapMap CEU population was performed using either MACH 46 or IMPUTE 47 . All SNPs with a MAF <0.01 were excluded from analysis. In total, up to 2.11 million genotyped or imputed SNPs were analyzed. In the replication step, we obtained only summary statistics for the loci of interest from GWA data of KORA F4 and SHIP. In CBR, the genotypes for the loci of interest were obtained using Sequenom iPLEX.
Blood count measurements. UK Blood Services Donor Panel 1 (UKBS-CC1).
Venous blood was taken from the dry pouch (attached to whole blood donation set) and placed in an EDTA-containing tube which was used to perform full blood counts (FBCs) on a Beckman-Coulter GenS automated blood count analyzer.
KORA F3 500K. DNA was extracted from fresh blood and was stored at −80 °C. FBCs were performed on fresh venous EDTA-anticoagulated blood using an automatic blood counter (Beckman Coulter STKS).
TwinsUK. Venous blood was anticoagulated with EDTA, and FBCs were performed using either an ADVIA 2120 Haematology System (Siemens Healthcare Diagnostics) or a ×E 2100 automated hematology analyzer (Sysmex) on average within 24 h from venesection (range 20-30 h). To account for different measurement ranges, association analyses were adjusted for instrument type.
KORA F4. DNA was extracted from fresh blood and was stored at −80 °C. FBCs were performed on fresh venous EDTA-anticoagulated blood using an automatic blood counter (Beckman Coulter LH 750).
Study of Health in Pomerania (SHIP).
Non-fasting blood samples were taken in the supine position. The blood count was measured within 60 min and the following counts were taken: erythrocytes, hemoglobin, hematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), platelets and leukocytes. Samples were analyzed either at the hospital laboratory in Greifswald with a Coulter Max M analyzer (Coulter Electronics) or at the hospital laboratory in Stralsund with a Coulter T660 analyzer (Coulter Electronics). Both analyzers were calibrated and maintained according to the manufacturers' instructions. Quality control was performed internally as well as externally through participation in external proficiency-testing programs.
Cambridge Bioresource (CBR). Blood was taken from the dry pouch (attached to whole blood donation set) and placed into an EDTA tube.
FBCs were performed on an ABX Pentra 60 Automated Hematology Analyzer (ABX Diagnostics). All samples were analyzed within 24 h of collection.
CAD and MI case-control associations studies. We used a two-stage approach to test the association of the 22 loci with CAD and MI. We obtained association statistics for each SNP from 4,021 cases and 5,879 controls from three European CAD and MI case-control studies (WTCCC-CAD (n = 1,924/2,937), GerMIFS I (n = 875/1,644) and GerMIFS II (n = 1,222/1,298), Supplementary Table 1b) and calculated the pooled odds ratios. Two SNPs from the 12q24 region that had nominal significance (P ≤ 0.05) in the stage 1 analysis were carried forward for replication in an additional 5,458 cases and 4,648 controls from five further case-control collections, including the Ottawa Heart (OHGS, n = 1,541/1,452), MedSTAR (n = 875/447), PennCATH (n = 933/468), MIGen (n = 1,275/1,407) and COROGENE (n = 833/871) studies. The characteristics of the eight case-control series are described in Supplementary Table 1b. Statistical analyses. Associations with hematological traits. Each study performed association analyses of blood traits using linear additive models on natural log-transformed (MPV, RBC and WBC) or untransformed (MCH, MCHC, PLT, MCV and Hb) variables after adjustment for age, gender and instrument (TwinsUK). Analyses were carried out using the software SNPTEST 47 (UKBS-CC1 and KORA F4), PLINK 48 (CBR) or MACH2QTL (KORA F3 500K). Imputed genotypes were tested for association after accounting for uncertainty using the 'PROPER' option in the SNPTEST software package 47 . Association analyses in the TwinsUK collection were carried out using a score test and variance components to adjust for family structure using the software MERLIN 49 .
Meta-analyses and signal prioritization. The results from all three GWA scans were combined into meta-analysis statistics using a weighted z-statistics method, where weights were proportional to the square root of the standard errors of the regression coefficients examined in each sample and selected such that the squared-weights sum would be 1 (ref. 50 ). Calculations were implemented in the METAL package. SNPs with MAF <0.01 and imputation quality <0.3 (MACH) or 0.4 (IMPUTE) were excluded from the analyses. The estimated genomic control parameters in each study were low (see Supplementary Note), suggesting little residual confounding due to population stratification. After meta-analysis, we applied the following filtering criteria to prioritize genomic regions for replication: (i) meta-analysis showed P ≤ 10 -5 , (ii) associations showed the same direction of effect in all three cohorts; (iii) at least two of the three cohorts showed associations with P ≤ 0.05 and the third had a P ≤ 0.1. Associated regions were considered independent if the SNPs were either unlinked or located at distances of ≥500 kb apart. Associations were considered genome-wide significant below P = 5 × 10 -8 , which corresponds to a Bonferroni correction for the estimated 1 million independent common variant tests in the human genome of European individuals 51 .
Multimarker score tests for MPV and MCV. We constructed a score to predict MPV levels from the joint model of the 12 validated MPV SNPs. We did not consider the three validated PLT loci, as none of them were significantly associated with MPV. For each sample, we calculated the expected mean from the linear regression coefficients of the primary analysis (in log units). We transformed these to the original units and further corrected these estimates for logarithmic transformation bias using the formula exp(0.5 × σ 2 ) = 1.005, where σ is the residual standard error 52 . We then computed the mean and standard error of MPV per number of MPV-increasing alleles as the means of the corrected predicted values using 1,814 individuals from the KORA F4 study. Due to their low numbers, we grouped individuals with ≤7 and ≥18 MPV-increasing alleles. Finally, we calculated the regression of mean on score. We used a similar approach to predict MCV levels for the six validated SNPs associated with red blood cell traits (rs5756506, rs11970772, rs1800562, rs9609565, rs9402686 and rs7385804). All calculations were performed on predicted, best-guess genotypes with the statistical analysis software R.
Conditional analyses. We investigated whether the MPV loci affected MPV independently of PLT in the three replication cohorts (CBR, SHIP and KORA F4) using conditional models where PLT was added as a covariate in the MPV regressions. The conditional analysis showed consistently stable effect sizes and P values for all but one SNP (rs11602954), a scenario compatible with the hypothesis that the primary effect of the SNP is on MPV (data not shown). For
